Related Experiment Video
Updated: Nov 30, 2025

Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Assessing hERG1 Blockade from Bayesian Machine-Learning-Optimized Site Identification by Ligand Competitive
Mahdi Mousaei1, Meruyert Kudaibergenova1, Alexander D MacKerell2
1Centre for Molecular Simulation, Department of Biological Sciences, University of Calgary, Calgary, Alberta T2N 1N4, Canada.
Drug-induced cardiotoxicity from hERG1 channel blockade is a common drug side effect. A new SILCS/BML computational method accurately predicts drug blockers, aiding safer drug development.
Area of Science:
- Computational Chemistry
- Pharmacology
- Biophysics
Background:
- Drug-induced cardiotoxicity is a significant clinical concern, often linked to hERG1 potassium channel blockade.
- Preclinical safety assessments for hERG1 blockade are costly and time-consuming.
- Advances in cryo-EM have enabled molecular modeling for drug-target interactions.
Purpose of the Study:
- To apply the Site Identification by Ligand Competitive Saturation (SILCS) protocol for mapping hERG1 channel hotspots.
- To develop a computational method for rapid assessment of drug cardiotoxicity potential.
- To salvage lead compounds by identifying key determinants of drug blockade.
Main Methods:
- Blind application of the SILCS protocol using small solutes to sample chemical space.
- Generation of FragMaps accounting for protein flexibility and interactions.
- Augmentation with a Bayesian-optimization/machine-learning (BML) stage for weighting FragMap contributions.
Main Results:
- SILCS/BML accurately predicted pIC50 values for 55 diverse hERG1 blockers (Pearson correlation > 0.535).
- The SILCS/BML model significantly outperformed traditional rigid and flexible docking methods.
- Accurate prediction requires proper weighting of drug protonation states at physiological pH.
Conclusions:
- The SILCS/BML approach provides a rapid and effective in silico method for screening cardiotoxic potential.
- This method can guide rational drug design, including the development of hERG1 activators.
- Optimized SILCS FragMaps offer a valuable tool for preclinical drug safety assessment.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Ligand Binding and Linkage